Bio-Techne (TECH) Misses Q4 EPS by 4c

August 17, 2016 7:03 AM EDT

Get access to the best calls on Wall Street with's Ratings Insider Elite. Get your Free Trial here.

Bio-Techne (NASDAQ: TECH) reported Q4 EPS of $0.92, $0.04 worse than the analyst estimate of $0.96. Revenue for the quarter came in at $134.8 million versus the consensus estimate of $129.23 million.

For earnings history and earnings-related data on Bio-Techne (TECH) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories


Related Entities


Add Your Comment